Anti‐VEGF vs no anti‐VEGF
Proportion of participants with relief of pain and resolution of redness, 1 year · people with neovascular glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
- Anti‐vascular endothelial growth factor for neovascular glaucoma 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found